Business and Finance

Software firm merges with PharmaLex Group

Collaboration, the companies note, is expected to further engage patients

A sit-down with members of the Deloitte team, who discuss the findings of the company’s yearly research and development report

Grows Syner-G’s presence in RTP, a biotech hub that continues to develop

CDMO will use its BFS knowledge to support production out of its Kaysersberg, France plant

Acquires Medaxis, a patient engagement company

Merger with Phlexglobal expands provider’s technological capabilities

Integrated system intends to accelerate enrollment by strengthening relationship between hub patient services and providers

Partnership looks to ensure that chargebacks for suppliers are as accurate as possible

CellShip offers an alternative to cryopreservation, the parties note

Companies to focus on market access strategies

Newly acquired Performance Cell Manufacturing will now be known as Cellipont Bioservices

CDMO's new South Korean facility to offer a range of production services

With the delivery of Covid-19 booster shots in full swing, how does this effort compare to the initial vaccine distribution—and is the pharma supply chain adapting accordingly?

Acquisition of 86,000 square-foot plant has capability of manufacturing 1.8 billion capsules annually

Deal helps expands software company’s labeling capabilities in clinical trial, med device and pharma spaces

Protagen, BioAnalytix and GeneWerk merger set to target biopharma, C&GT sectors

Tufts analysis uncovers various benefits to conducting decentralized clinical trials—including financial benefits

Acquisition of AcKnowledge RS also expands company's IVD expertise

Partnership enhances CBM’s manufacturing capabilities in C&GT space

Syneos Health’s annual survey reveals the potential for shifts in the M&A space

Marks the first step in two-phase facility expansion project

Collaboration aims to prioritize best practices in fields of biopreservation and closed-system manufacturing, while improving children’s health

The shot—which could be the first one to be mRNA based—is scheduled to begin clinical trials later this year

Development project features 150,000 square feet of additional space to accommodate company’s 3PL offerings